FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
Top NewsMost Read Highlighted
Get AlertsIRWD Hot Sheet
Rating Summary:
6 Buy, 5 Hold, 3 Sell
Rating Trend: Up
Today’s Overall Ratings:
UBS downgraded Ironwood Pharmaceuticals (NASDAQ: IRWD) from Neutral to Sell.
For an analyst ratings summary and ratings history on Ironwood Pharmaceuticals click here. For more ratings news on Ironwood Pharmaceuticals click here.
Shares of Ironwood Pharmaceuticals closed at $14.69 yesterday, with a 52 week range of $10.01-$15.92.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items – JOIN NOW